AAAAAA
Results:
1-7
|
Results: 7
Authors:
SCHNELL R
VITETTA E
SCHINDLER J
BARTH S
WINKLER U
BORCHMANN P
HANSMANN ML
DIEHL V
GHETIE V
ENGERT A
Citation: R. Schnell et al., CLINICAL-TRIALS WITH AN ANTI-CD25 RICIN A-CHAIN EXPERIMENTAL AND IMMUNOTOXIN (RFT5-SMPT-DGA) IN HODGKINS-LYMPHOMA, Leukemia & lymphoma, 30(5-6), 1998, pp. 525
Authors:
SCHNELL R
VITETTA E
SCHINDLER J
BOHLEN H
HANSMANN ML
BARTH S
GHETIE V
UHR J
DIEHLL V
ENGERT A
Citation: R. Schnell et al., A CLINICAL-PHASE-I II TRIAL WITH AN ANTI-CD25 RICIN A-CHAIN IMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS LYMPHOMA/, Blood, 90(10), 1997, pp. 1517-1517
Authors:
ENGERT A
DIEHL V
SCHNELL R
RADSZUHN A
HATWIG MT
DRILLICH S
SCHON G
BOHLEN H
TESCH H
HANSMANN ML
BARTH S
SCHINDLER J
GHETIE V
UHR J
VITETTA E
Citation: A. Engert et al., A PHASE-I STUDY OF AN ANTI-CD25 RICIN A-CHAIN IMMUNOTOXIN (RFT5-SMPT-DGA) IN PATIENTS WITH REFRACTORY HODGKINS LYMPHOMA, Blood, 89(2), 1997, pp. 403-410
Authors:
SENDEROWICZ AM
VITETTA E
HEADLEE D
GHETIE V
UHR JW
FIGG WD
LUSH RM
STETLERSTEVENSON M
KERSHAW G
KINGMA DW
JAFFE ES
SAUSVILLE EA
Citation: Am. Senderowicz et al., COMPLETE SUSTAINED RESPONSE OF A REFRACTORY, POSTTRANSPLANTATION, LARGE B-CELL LYMPHOMA TO AN ANTI-CD22 IMMUNOTOXIN, Annals of internal medicine, 126(11), 1997, pp. 882-885
Authors:
NOON E
GHETIE V
VITETTA E
Citation: E. Noon et al., DECREASING THE IMMUNOGENICITY OF RICIN A-CHAIN, The FASEB journal, 8(4), 1994, pp. 10000505-10000505
Authors:
GHETIE V
VITETTA E
Citation: V. Ghetie et E. Vitetta, IMMUNOTOXINS IN THE THERAPY OF CANCER - FROM BENCH TO CLINIC, Pharmacology & therapeutics, 63(3), 1994, pp. 209-234
Authors:
TONG AW
HUANG YW
GHETIE V
NEMUNAITIS J
PINEIRO L
VITETTA E
STONE MJ
Citation: Aw. Tong et al., ENHANCEMENT OF ANTI-CD54 IMMUNOTOXIN CYTOTOXICITY TO HUMAN MULTIPLE-MYELOMA CELLS BY CYCLOSPORINE DRUGS, Blood, 84(10), 1994, pp. 10000170-10000170
Risultati:
1-7
|